- Patent Title: Transdermal delivery system containing galantamine or salts thereof
-
Application No.: US15215302Application Date: 2016-07-20
-
Publication No.: US10758546B2Publication Date: 2020-09-01
- Inventor: Hoo-kyun Choi , Myung-kwan Chun
- Applicant: Industry-Academic Cooperation Foundation, Chosun University , TAHO Pharmaceuticals Ltd.
- Applicant Address: KR Gwangju TW Taipei
- Assignee: Industry-Academic Cooperation Foundation,TAHO Pharmaceuticals Ltd.
- Current Assignee: Industry-Academic Cooperation Foundation,TAHO Pharmaceuticals Ltd.
- Current Assignee Address: KR Gwangju TW Taipei
- Agency: Leason Ellis LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6810db57
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K9/70 ; A61K47/32 ; A61K47/14
Abstract:
The present invention provides a transdermal delivery system, which comprises a drug-containing matrix layer comprising: galantamine or its pharmaceutically acceptable salt as an active ingredient; and a styrene-butadiene-styrene copolymer or a styrene-isoprene-styrene copolymer as an adhesive.
Public/Granted literature
- US20160339038A1 TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF Public/Granted day:2016-11-24
Information query
